US 12005074
Extrahepatic delivery
granted A61KA61K31/713A61K47/543
Quick answer
US patent 12005074 (Extrahepatic delivery) held by Alnylam Pharmaceuticals, Inc. expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/713, A61K47/543, A61K47/549, A61K47/55